Ana Bosch Selected Research

Ana Bosch Research Topics

Disease

21	Neoplasms (Cancer) 01/2024 - 09/2007
19	Breast Neoplasms (Breast Cancer) 01/2024 - 04/2009
5	Neoplasm Metastasis (Metastasis) 06/2023 - 09/2007
4	Triple Negative Breast Neoplasms 10/2023 - 05/2010
2	Carcinogenesis 06/2023 - 01/2021
1	Inflammation (Inflammations) 08/2022
1	Disease Progression 01/2021
1	Pathologic Complete Response 01/2021
1	Melanoma (Melanoma, Malignant) 01/2019
1	Residual Neoplasm 03/2014
1	Margins of Excision 09/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2003
1	Brain Neoplasms (Brain Tumor) 01/2003

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2016
6	Estrogen ReceptorsIBA 11/2021 - 08/2010
3	Caveolin 1IBA 01/2024 - 08/2022
3	Trastuzumab (Herceptin)FDA Link 01/2023 - 04/2014
3	Phenobarbital (Luminal)FDA Link 08/2022 - 08/2010
3	RNA (Ribonucleic Acid)IBA 11/2021 - 01/2020
3	Fulvestrant (Faslodex)FDA Link 01/2021 - 04/2015
3	Hormones (Hormone)IBA 01/2021 - 12/2011
2	Indicators and Reagents (Reagents)IBA 01/2024 - 08/2010
2	Docetaxel (Taxotere)FDA Link 01/2023 - 01/2021
2	pertuzumabIBA 01/2023 - 01/2021
2	Ado-Trastuzumab EmtansineIBA 01/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 11/2021 - 08/2010
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2021
2	Tamoxifen FDA LinkGeneric 11/2021 - 08/2010
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2015 - 03/2014
1	thymidine kinase 1IBA 01/2024
1	Epidermal Growth Factor (EGF)IBA 01/2024
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2024
1	Insulin (Novolin)FDA Link 08/2022
1	Insulin-Like Growth Factor Binding ProteinsIBA 11/2021
1	Hematoxylin (Haematoxylon)IBA 10/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2021
1	CyclinsIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	RNA Helicases (RNA Helicase)IBA 01/2019
1	DEAD-box RNA HelicasesIBA 01/2019
1	Microphthalmia-Associated Transcription FactorIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	capivasertibIBA 01/2018
1	CholesterolIBA 09/2016
1	Atorvastatin (Lipitor)FDA Link 09/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2016
1	AlpelisibIBA 04/2015
1	ParaffinIBA 07/2014
1	MicroRNAs (MicroRNA)IBA 07/2014
1	MTOR InhibitorsIBA 07/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2014
1	NVP-BKM120IBA 04/2014
1	ErbB Receptors (EGF Receptor)IBA 03/2014
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 03/2014
1	AntibodiesIBA 03/2014
1	MEHD7945AIBA 03/2014
1	ipatasertibIBA 03/2014
1	Cetuximab (Erbitux)FDA Link 03/2014
1	ClaudinsIBA 10/2012
1	CarcinogensIBA 08/2010
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2010
1	Platinum Compounds (Compounds, Platinum)IBA 05/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2010
1	AnthracyclinesIBA 04/2009
1	taxaneIBA 04/2009
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2003
1	Cisplatin (Platino)FDA LinkGeneric 01/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2003
1	Gemcitabine FDA Link 01/2003

Therapy/Procedure

9	Therapeutics 07/2023 - 01/2003
4	Drug Therapy (Chemotherapy) 08/2010 - 01/2003
3	Neoadjuvant Therapy 01/2023 - 09/2007
1	Segmental Mastectomy (Lumpectomy) 01/2021
1	Length of Stay 09/2007
1	TP protocol 01/2003